We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+6.44%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$350M
AUM Growth
+$9.81M
(+2.9%)
Cap. Flow
-$17.4M
Cap. Flow
% of AUM
-4.98%
Top 10 Holdings %
Top 10 Hldgs %
22.15%
Holding
984
New
159
Increased
201
Reduced
274
Closed
107
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$7.69M |
| 2 |
RSX
VanEck Russia ETF
RSX
|
+$6.34M |
| 3 |
abrdn Physical Gold Shares ETF
SGOL
|
+$5.37M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$4.77M |
| 5 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$4.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.86M |
| 2 |
Stellantis
STLA
|
+$5.95M |
| 3 |
iShares MSCI China ETF
MCHI
|
+$5.61M |
| 4 |
iShares MSCI South Africa ETF
EZA
|
+$3.63M |
| 5 |
VanEck Oil Services ETF
OIH
|
+$3.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.27% |
| 2 | Technology | 10.8% |
| 3 | Consumer Discretionary | 10.51% |
| 4 | Financials | 9.65% |
| 5 | Materials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Vanguard FTSE Developed Markets ETF
VEA
$227B
| $117K | 0.03% |
+2,375
| New | +$116K |
|
402
Kodak
KODK
$780M
| $116K | 0.03% |
14,767
+2,979
| +25% | +$27.1K |
|
403
Bumble
BMBL
$386M
| $114K | 0.03% |
+1,833
| New | +$123K |
|
404
Aurinia Pharmaceuticals
AUPH
$1.99B
| $113K | 0.03% |
8,740
-1,388
| -14% | -$20.1K |
|
405
CALL
Ferrari
RACE
$66.6B
| $112K | 0.03% |
151
+133
| +739% | +$27.2K |
|
|
406
PUT
Linde
LIN
$235B
| $111K | 0.03% |
349
+211
| +153% | +$54.7K |
|
407
iShares MSCI United Kingdom ETF
EWU
$4.06B
| $110K | 0.03% |
+3,527
| New | +$109K |
|
408
Talphera
TLPH
$65.4M
| $110K | 0.03% |
+3,238
| New | +$129K |
|
409
Rhythm Pharmaceuticals
RYTM
$7.37B
| $110K | 0.03% |
5,167
-1,007
| -16% | -$29.2K |
|
|
CONE
410
DELISTED
CyrusOne Inc Common Stock
CONE
| $109K | 0.03% |
1,610
-5,215
| -76% | -$362K |
|
411
Warner Bros
WBD
$63.7B
| $109K | 0.03% |
+2,500
| New | +$125K |
|
412
Rapid7
RPD
$655M
| $109K | 0.03% |
1,456
+1,006
| +224% | +$83.6K |
|
413
MasTec
MTZ
$26.3B
| $108K | 0.03% |
1,157
+224
| +24% | +$19.2K |
|
414
Workhorse Group
WKHS
$30.4M
| $108K | 0.03% |
3
-1
| -25% | -$71.8K |
|
415
BioNTech
BNTX
$23.2B
| $107K | 0.03% |
978
| – | – |
|
416
iShares US Financial Services ETF
IYG
$2.15B
| $106K | 0.03% |
1,860
| – | – |
|
417
Lennar Class A
LEN
$20.4B
| $105K | 0.03% |
1,072
-165
| -13% | -$13.9K |
|
418
Tencent Music
TME
$15.2B
| $104K | 0.03% |
5,100
-20,230
| -80% | -$513K |
|
|
PARAA
419
DELISTED
Paramount Global Class A
PARAA
| $104K | 0.03% |
+2,200
| New | +$135K |
|
420
LyondellBasell Industries
LYB
$19B
| $102K | 0.03% |
977
+678
| +227% | +$67.3K |
|
421
BridgeBio Pharma
BBIO
$16.6B
| $101K | 0.03% |
1,638
+1,143
| +231% | +$74.8K |
|
422
Nuveen Credit Strategies Income Fund
JQC
$704M
| $101K | 0.03% |
15,500
| – | – |
|
423
Global X US Infrastructure Development ETF
PAVE
$14.1B
| $100K | 0.03% |
+4,000
| New | +$92K |
|
424
nCino
NCNO
$1.98B
| $100K | 0.03% |
1,500
+750
| +100% | +$53.5K |
|
425
Palantir
PLTR
$315B
| $96.1K | 0.03% |
4,127
-3,362
| -45% | -$92.2K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q1 2021 Portfolio in Review
As of Q1 2021, Exane Derivatives held 984 positions worth $350M, up 2.9% from $340M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Exane Derivatives withdrew a net $17.4M in Q1 2021, closing 107 positions and reducing 274 holdings. Its most notable exit was Amazon, an estimated $6.86M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Exane Derivatives opened a new position in Linde worth $11.3M.
- Exane Derivatives's largest Q1 2021 buy was Linde: 29,643 shares worth $11.3M.
- Exane Derivatives added most to VanEck Russia ETF in Q1 2021, an estimated $6.34M increase.
- Exane Derivatives's biggest Q1 2021 reduction was Stellantis, cutting an estimated $5.95M.
- Exane Derivatives fully exited Amazon in Q1 2021, selling an estimated $6.86M.
- Exane Derivatives's ten largest holdings make up 22% of its $350M portfolio in Q1 2021.
- Exane Derivatives opened 159 new positions and closed 107 in Q1 2021.
- Exane Derivatives's portfolio value rose 2.9% quarter-over-quarter to $350M.
Based on Exane Derivatives's 13F filing for Q1 2021, filed 30 Apr 2021.